Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

67
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
67
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

2.8K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.8K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytokine changes during a 12-month pragmatic randomized trial in schizophrenia spectrum disorders comparing amisulpride, aripiprazole and olanzapine.

Psychiatry research·2026
Same author

A Clinical Investigation of Hypoxic Red Blood Cell Administration in Patients with Transfusion-Dependent Hematological Malignancies and Burns.

Journal of blood medicine·2026
Same author

Pre-transplant microRNA serum profiles and association with acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.

Frontiers in immunology·2026
Same author

Endothelial mediators and association with chronic graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: a retrospective single-center study.

Cytotherapy·2026
Same author

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same author

Metabolomics profiling of acute myelogenous leukemia patients to identify systemic differences associated with in vitro sensitivity to SYK inhibitors.

Metabolomics : Official journal of the Metabolomic Society·2026

Related Experiment Video

Updated: Sep 26, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

292

Endocan in Acute Leukemia: Current Knowledge and Future Perspectives.

Håkon Reikvam1,2, Kimberley Joanne Hatfield3, Øystein Wendelbo2

  • 1Department of Clinical Science, University of Bergen, 5020 Bergen, Norway.

Biomolecules
|April 23, 2022
PubMed
Summary

Endocan, a proteoglycan, shows promise as a prognostic marker in acute leukemia. Its levels may predict complications and mortality, suggesting potential for targeted therapies.

Keywords:
acute leukemiaallogeneic stem cell transplantationchemotherapycytopeniaendocanfluid overloadnonrelapse mortalityp14 endocan fragmentprotease

More Related Videos

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.2K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.3K

Related Experiment Videos

Last Updated: Sep 26, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

292
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.2K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.3K

Area of Science:

  • Biochemistry
  • Oncology
  • Immunology

Background:

  • Endocan is a soluble proteoglycan found in endothelial cells and blood.
  • Elevated endocan levels correlate with poor prognosis in various cancers.
  • Endocan and its p14 fragment may indicate different biological aspects, with endocan potentially better reflecting acute leukemia heterogeneity.

Purpose of the Study:

  • To review the prognostic significance of endocan in acute leukemia.
  • To explore endocan's role in complications like nonrelapse mortality and cytokine release syndrome.
  • To assess the potential for therapeutic targeting of endocan in acute leukemia.

Main Methods:

  • Review of existing clinical studies and previously unpublished data.
  • Analysis of serum/plasma endocan and p14 fragment levels.
  • Correlation of endocan levels with patient outcomes, including mortality and complications.

Main Results:

  • Endocan levels appear to better reflect acute leukemia heterogeneity than p14 fragment levels.
  • Decreased endocan is linked to respiratory complications in sepsis, but its role in immunocompromised leukemia patients is unclear.
  • High endocan is associated with increased early nonrelapse mortality post-stem cell transplantation, independent of fluid overload.

Conclusions:

  • Endocan holds potential as a prognostic biomarker in acute leukemia.
  • Further research is needed to validate endocan's predictive value for complications and long-term outcomes.
  • Therapeutic targeting of endocan warrants investigation for acute leukemia treatment strategies.